Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) Research & Development (2016 - 2025)

Bio Key International (BKYI) has disclosed Research & Development for 16 consecutive years, with $683620.0 as the latest value for Q3 2025.

  • Quarterly Research & Development rose 4.82% to $683620.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Sep 2025, up 4.37% year-over-year, with the annual reading at $2.5 million for FY2024, 4.85% up from the prior year.
  • Research & Development hit $683620.0 in Q3 2025 for Bio Key International, up from $636027.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $833381.0 in Q4 2022 to a low of $441651.0 in Q1 2021.
  • Historically, Research & Development has averaged $654143.2 across 5 years, with a median of $636027.0 in 2025.
  • Biggest five-year swings in Research & Development: soared 97.64% in 2021 and later crashed 36.14% in 2023.
  • Year by year, Research & Development stood at $809856.0 in 2021, then rose by 2.9% to $833381.0 in 2022, then fell by 25.98% to $616829.0 in 2023, then grew by 7.02% to $660151.0 in 2024, then grew by 3.56% to $683620.0 in 2025.
  • Business Quant data shows Research & Development for BKYI at $683620.0 in Q3 2025, $636027.0 in Q2 2025, and $595775.0 in Q1 2025.